Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

SPINEWAY : Liquidity contract half-yearly report

SPINEWAY
Posted on: 10 Jul 18

Press release                                                                                                                                                                              Ecully, 10 July 2018

LIQUIDITY CONTRACT HALF-YEARLY REPORT

Regarding liquidity contract granted by SPINEWAY to PORTZAMPARC, the liquidity account held the following assets on June 30 th 2018:

  • 37,149 shares SPINEWAY ,
  • 13,599.76 € .

At December 31 st 2017 report, the position of this liquidity contract was:

  • 21,622 shares SPINEWAY ,
  • 28,569.76 €.

Next communication: Revenue for the first half of 2018 - 11 July 2018 after market closes

SPINEWAY IS ELIGIBLE FOR THE PEA-PME (EQUITY SAVINGS PLAN FOR SMES)
Find out all about Spineway at www.spineway.com

This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.

Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.
Spineway has an international network of over 50 independent distributors and 90% of its turnover comes from exports.
Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), received the OSEO Excellence award as well as the Deloitte Fast 50 award in 2011. Rhône Alpes INPI Patent Innovation Award (2013) - Talent INPI award (2015).
ISIN code: FR0011398874 - ALSPW     


Investor Relations
David Siegrist - Finance Director
Tel : +33 (0)4 72 77 01 52
finance.dsg@spineway.com
Financial Communication
Jérôme Gacoin / Solène Kennis
Tel: +33 (0)1 75 77 54 68
skennis@aelium.fr
Liquidity contract half-yearly report


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: SPINEWAY via GlobeNewswire
HUG#2204247
GlobeNewswire
globenewswire.com

Last updated on: 11/07/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.